Glucose and antidiabetic therapy in temozolomide resistance in glioblastoma

Emir Begagić, Amina Džidić-Krivić, Hakija Bečulić, Ragib Pugonja, Adnana Ljevaković, Binasa Bašić, Adem Nuhović, Elma Milanović, Semir Hadžić, Emir Bećirović, Lemana Buljubašić, Minela Bećirović, Mirza Pojskić

Open source

DOI: 10.5306/wjco.v16.i8.108112
Published: 2025-08-24
Container: World Journal of Clinical Oncology
Publisher: Baishideng Publishing Group Inc.
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.5306/wjco.v16.i8.108112,
  title = {Glucose and antidiabetic therapy in temozolomide resistance in glioblastoma},
  author = {Emir Begagić and Amina Džidić-Krivić and Hakija Bečulić and Ragib Pugonja and Adnana Ljevaković and Binasa Bašić and Adem Nuhović and Elma Milanović and Semir Hadžić and Emir Bećirović and Lemana Buljubašić and Minela Bećirović and Mirza Pojskić},
  year = {2025},
  journal = {World Journal of Clinical Oncology},
  doi = {10.5306/wjco.v16.i8.108112},
  url = {https://doi.org/10.5306/wjco.v16.i8.108112}
}

RIS

TY  - JOUR
TI  - Glucose and antidiabetic therapy in temozolomide resistance in glioblastoma
AU  - Emir Begagić
AU  - Amina Džidić-Krivić
AU  - Hakija Bečulić
AU  - Ragib Pugonja
AU  - Adnana Ljevaković
AU  - Binasa Bašić
AU  - Adem Nuhović
AU  - Elma Milanović
AU  - Semir Hadžić
AU  - Emir Bećirović
AU  - Lemana Buljubašić
AU  - Minela Bećirović
AU  - Mirza Pojskić
PY  - 2025
JO  - World Journal of Clinical Oncology
DO  - 10.5306/wjco.v16.i8.108112
UR  - https://doi.org/10.5306/wjco.v16.i8.108112
ER  -

APA

Begagić, E., Džidić-Krivić, A., Bečulić, H., Pugonja, R., Ljevaković, A., Bašić, B., Nuhović, A., Milanović, E., Hadžić, S., Bećirović, E., Buljubašić, L., Bećirović, M., & Pojskić, M. (2025). Glucose and antidiabetic therapy in temozolomide resistance in glioblastoma. World Journal of Clinical Oncology. https://doi.org/10.5306/wjco.v16.i8.108112

Source records

crossref · retrieved 2026-09-26T16:26:47.118Z